Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE CANADA SPECIALTY PHARMACY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 SERVICES LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
5 CANADA SPECIALTY PHARMACY MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF CHRONIC AND RARE DISEASES
6.1.2 INCREASING GERIATRIC POPULATION
6.1.3 INCREASING NUMBER OF DISTRIBUTION CHANNELS FOR SPECIALITY DRUGS
6.2 RESTRAINTS
6.2.1 STRINGENT REGULATORY FRAMEWORK
6.2.2 LACK OF SKILLED PHARMACISTS
6.3 OPPORTUNITIES
6.3.1 EMERGING MARKETS OF SPECIALTY PHARMACIES
6.3.2 RISING E-PHARMACIES FACILITIES
6.4 CHALLENGES
6.4.1 LACK OF AWARENESS AMONG CONSUMERS ABOUT SPECIALTY PHARMACIES
6.4.2 INSUFFICIENT FUNDING FOR SPECIALITY PHARMACIES
7 CANADA SPECIALTY PHARMACY MARKET, BY TYPE
7.1 OVERVIEW
7.2 LARGE PHARMACY BENEFIT MANAGER (PBM)
7.2.1 MANUFACTURER-OWNED SPECIALTY PHARMACIES
7.2.2 OWNED SPECIALTY PHARMACIES
7.3 SMALL-INDEPENDENT PHARMACY SERVICE PROVIDERS
8 CANADA SPECIALTY PHARMACY MARKET, BY SERVICE TYPE
8.1 OVERVIEW
8.2 CLINICAL SERVICES
8.2.1 COMPOUNDING
8.2.2 AUTO-REFILLS/REFILLS
8.2.3 BLISTER PACKAGING
8.2.4 MEDICAL CONSULTATIONS
8.2.5 CARE MANAGEMENT
8.2.6 PATIENT ADHERENCE PROGRAMS
8.2.7 HEALTH CARE PROVIDER ACCESS
8.2.8 CLINICAL OUTCOME MEASURES
8.2.9 RISK EVALUATION AND MITIGATION STRATEGIES (REMS) PROGRAMS
8.3 OPERATIONAL SERVICES
8.3.1 SUPPLY CHAIN MANAGEMENT
8.3.2 CARE COORDINATION
8.3.3 INSURANCE NAVIGATION
8.3.4 PATIENT ASSISTANCE
8.3.5 PLAN OPTIMIZATION
9 CANADA SPECIALTY PHARMACY MARKET, BY CONDITION
9.1 OVERVIEW
9.2 CANCER
9.3 RHEUMATOID ARTHRITIS
9.4 MULTIPLE SCLEROSIS
9.5 OSTEOARTHRITIS
9.6 INFERTILITY
9.7 HIV
9.8 PULMONARY HYPERTENSION
9.9 IMMUNE DEFICIENCY
9.1 ANEMIA
9.11 HEMOPHILIA
9.12 PSORIASIS
9.13 CYSTIC FIBROSIS
9.14 ULCERATIVE COLITIS
9.15 CROHN'S DISEASE
9.16 JUVENILE IDIOPATHIC ARTHRITIS
9.17 GROWTH HORMONE DEFICIENCIES
9.18 HEPATITIS C VIRUS
9.19 OTHERS
10 CANADA SPECIALTY PHARMACY MARKET, COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: GLOBAL
11 SWOT ANALYSIS
12 COMPANY PROFILES
12.1 MCKESSON CANADA
12.1.1 COMPANY SNAPSHOT
12.1.2 SERVICE PORTFOLIO
12.1.3 RECENT DEVELOPMENTS
12.2 SOBEYS INC.
12.2.1 COMPANY SNAPSHOT
12.2.2 SERVICE PORTFOLIO
12.2.3 RECENT DEVELOPMENTS
12.3 REXALL PHARMACY GROUP LTD.
12.3.1 COMPANY SNAPSHOT
12.3.2 SERVICE PORTFOLIO
12.3.3 RECENT DEVELOPMENTS
12.4 BAYSHORE HEALTHCARE
12.4.1 COMPANY SNAPSHOT
12.4.2 SERVICE PORTFOLIO
12.4.3 RECENT DEVELOPMENTS
12.5 PHARMASAVE
12.5.1 COMPANY SNAPSHOT
12.5.2 SERVICE PORTFOLIO
12.5.3 RECENT DEVELOPMENTS
12.6 AARONSON'S COMPOUNDING PHARMACY
12.6.1 COMPANY SNAPSHOT
12.6.2 SERVICE PORTFOLIO
12.6.3 RECENT DEVELOPMENTS
12.7 ANCHOR COMPOUNDING PHARMACY
12.7.1 COMPANY SNAPSHOT
12.7.2 SERVICE PORTFOLIO
12.7.3 RECENT DEVELOPMENTS
12.8 ABBY PHARMACY
12.8.1 COMPANY SNAPSHOT
12.8.2 SERVICE PORTFOLIO
12.8.3 RECENT DEVELOPMENTS
12.9 AURORA HEALTHCARE
12.9.1 COMPANY SNAPSHOT
12.9.2 SERVICE PORTFOLIO
12.9.3 RECENT DEVELOPMENTS
12.1 ALLCURES PHARMACY
12.10.1 COMPANY SNAPSHOT
12.10.2 SERVICE PORTFOLIO
12.10.3 RECENT DEVELOPMENTS
12.11 ALPINE DRUG MART I.D.A.
12.11.1 COMPANY SNAPSHOT
12.11.2 PRODUCT PORTFOLIO
12.11.3 RECENT DEVELOPMENTS
12.12 ANDREEN'S PHARMACY
12.12.1 COMPANY SNAPSHOT
12.12.2 SERVICE PORTFOLIO
12.12.3 RECENT DEVELOPMENTS
12.13 BRUNSKILLPHARMACY
12.13.1 COMPANY SNAPSHOT
12.13.2 SERVICE PORTFOLIO
12.13.3 RECENT DEVELOPMENTS
12.14 BAINS PHARMACY
12.14.1 COMPANY SNAPSHOT
12.14.2 PRODUCT PORTFOLIO
12.14.3 RECENT DEVELOPMENTS
12.15 BIOSCRIPT SOLUTIONS
12.15.1 COMPANY SNAPSHOT
12.15.2 SERVICE PORTFOLIO
12.15.3 RECENT DEVELOPMENTS
12.16 BUDGET PHARMACY
12.16.1 COMPANY SNAPSHOT
12.16.2 SERVICE PORTFOLIO
12.16.3 RECENT DEVELOPMENTS
12.17 BALANCED HEALTH INTEGRATIVE PHARMACY
12.17.1 COMPANY SNAPSHOT
12.17.2 SERVICE PORTFOLIO
12.17.3 RECENT DEVELOPMENTS
12.18 COMPOUNDING PHARMACY NEW WESTMINSTER - LONGEVITY PHARMACY
12.18.1 COMPANY SNAPSHOT
12.18.2 SERVICE PORTFOLIO
12.18.3 RECENT DEVELOPMENTS
12.19 CITY LIFE PHARMACY
12.19.1 COMPANY SNAPSHOT
12.19.2 SERVICE PORTFOLIO
12.19.3 RECENT DEVELOPMENTS
12.2 CREATE COMPOUNDING LIMITED
12.20.1 COMPANY SNAPSHOT
12.20.2 SERVICE PORTFOLIO
12.20.3 RECENT DEVELOPMENTS
12.21 CONCORD SPECIALTY PHARMACY
12.21.1 COMPANY SNAPSHOT
12.21.2 SERVICE PORTFOLIO
12.21.3 RECENT DEVELOPMENTS
12.22 360CARE DENMAN PHARMACY
12.22.1 COMPANY SNAPSHOT
12.22.2 SERVICE PORTFOLIO
12.22.3 RECENT DEVELOPMENTS
12.23 DYNASTY PHARMACY
12.23.1 COMPANY SNAPSHOT
12.23.2 SERVICE PORTFOLIO
12.23.3 RECENT DEVELOPMENTS
12.24 EXTEND PHARMACY
12.24.1 COMPANY SNAPSHOT
12.24.2 SERVICE PORTFOLIO
12.24.3 RECENT DEVELOPMENTS
12.25 LONDON DRUGS
12.25.1 COMPANY SNAPSHOT
12.25.2 SERVICE PORTFOLIO
12.25.3 RECENT DEVELOPMENTS
12.26 LOVELL DRUGS
12.26.1 COMPANY SNAPSHOT
12.26.2 SERVICE PORTFOLIO
12.26.3 RECENT DEVELOPMENTS
12.27 MEDICINE CENTRE
12.27.1 COMPANY SNAPSHOT
12.27.2 SERVICE PORTFOLIO
12.27.3 RECENT DEVELOPMENTS
12.28 MOUNTAIN HEALTH CO-OP
12.28.1 COMPANY SNAPSHOT
12.28.2 SERVICE PORTFOLIO
12.28.3 RECENT DEVELOPMENTS
12.29 MEDS WEST LTD.
12.29.1 COMPANY SNAPSHOT
12.29.2 SERVICE PORTFOLIO
12.29.3 RECENT DEVELOPMENTS
12.3 MCCALLUM PHARMACY
12.30.1 COMPANY SNAPSHOT
12.30.2 SERVICE PORTFOLIO
12.30.3 RECENT DEVELOPMENTS
12.31 NORTHMOUNT PHARMACY AND COMPOUNDING LAB
12.31.1 COMPANY SNAPSHOT
12.31.2 SERVICE PORTFOLIO
12.31.3 RECENT DEVELOPMENTS
12.32 NKS HEALTH
12.32.1 COMPANY SNAPSHOT
12.32.2 SERVICE PORTFOLIO
12.32.3 RECENT DEVELOPMENTS
12.33 ONPHARM-UNITED
12.33.1 COMPANY SNAPSHOT
12.33.2 SERVICE PORTFOLIO
12.33.3 RECENT DEVELOPMENTS
12.34 OMNICARE PHARMACY
12.34.1 COMPANY SNAPSHOT
12.34.2 SERVICE PORTFOLIO
12.34.3 RECENT DEVELOPMENTS
12.35 OMNICELL INC.
12.35.1 COMPANY SNAPSHOT
12.35.2 REVENUE ANALYSIS
12.35.3 SERVICE PORTFOLIO
12.35.4 RECENT DEVELOPMENT
12.36 PHARMACHOICE CANADA INC.
12.36.1 COMPANY SNAPSHOT
12.36.2 SERVICE PORTFOLIO
12.36.3 RECENT DEVELOPMENTS
12.37 PRATT'S COMPOUNDING PHARMACY
12.37.1 COMPANY SNAPSHOT
12.37.2 SERVICE PORTFOLIO
12.37.3 RECENT DEVELOPMENTS
12.38 PACE PHARMACY
12.38.1 COMPANY SNAPSHOT
12.38.2 SERVICE PORTFOLIO
12.38.3 RECENT DEVELOPMENTS
12.39 QUIICK MEDICINE
12.39.1 COMPANY SNAPSHOT
12.39.2 SERVICE PORTFOLIO
12.39.3 RECENT DEVELOPMENTS
12.4 RX CONNECT
12.40.1 COMPANY SNAPSHOT
12.40.2 SERVICE PORTFOLIO
12.40.3 RECENT DEVELOPMENTS
12.41 RIVERVIEWGUARDIAN.CA
12.41.1 COMPANY SNAPSHOT
12.41.2 SERVICE PORTFOLIO
12.41.3 RECENT DEVELOPMENTS
12.42 RESIDENT CARE PHARMACY
12.42.1 COMPANY SNAPSHOT
12.42.2 SERVICE PORTFOLIO
12.42.3 RECENT DEVELOPMENTS
12.43 SHERMANSPECIALTY PHARMACY
12.43.1 COMPANY SNAPSHOT
12.43.2 SERVICE PORTFOLIO
12.43.3 3.43.3. RECENT DEVELOPMENTS
12.44 SHOPPERS DRUG MART SPECIALTY HEALTH NETWORK INC.
12.44.1 COMPANY SNAPSHOT
12.44.2 SERVICE PORTFOLIO
12.44.3 RECENT DEVELOPMENTS
12.45 SRX HEALTH
12.45.1 COMPANY SNAPSHOT
12.45.2 SERVICE PORTFOLIO
12.45.3 RECENT DEVELOPMENTS
12.46 SENTREX HEALTH SOLUTIONS
12.46.1 COMPANY SNAPSHOT
12.46.2 SERVICE PORTFOLIO
12.46.3 RECENT DEVELOPMENTS
12.47 TORANI AND HADDAD PHARMACY SPEC- PHARMA
12.47.1 COMPANY SNAPSHOT
12.47.2 SERVICE PORTFOLIO
12.47.3 RECENT DEVELOPMENTS
12.48 TOTAL PHARMACY
12.48.1 COMPANY SNAPSHOT
12.48.2 SERVICE PORTFOLIO
12.48.3 RECENT DEVELOPMENTS
12.49 VICTORIA COMPOUNDING PHARMACY
12.49.1 COMPANY SNAPSHOT
12.49.2 SERVICE PORTFOLIO
12.49.3 RECENT DEVELOPMENTS
12.5 WEST END PHARMACY
12.50.1 COMPANY SNAPSHOT
12.50.2 SERVICE PORTFOLIO
12.50.3 RECENT DEVELOPMENTS
13 QUESTIONNAIRE
14 RELATED REPORTS
List of Table
TABLE 1 CANADA SPECIALTY PHARMACY MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 2 CANADA LARGE PHARMACY BENEFIT MANAGER (PBM) IN SPECIALTY PHARMACY MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 3 CANADA SPECIALTY PHARMACY MARKET, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 4 CANADA CLINICAL SERVICES IN SPECIALTY PHARMACY MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 5 CANADA MEDICAL CONSULTATIONS IN SPECIALTY PHARMACY MARKET, BY TYPE 2018-2032 (USD MILLION)
TABLE 6 CANADA RISK EVALUATION AND MITIGATION STRATEGY (REMS) PROGRAMS IN SPECIALTY PHARMACY MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 7 CANADA OPERATIONAL SERVICES IN SPECIALTY PHARMACY MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 8 CANADA SUPPLY CHAIN MANAGEMENT IN SPECIALTY PHARMACY MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 9 CANADA INSURANCE NAVIGATION IN SPECIALTY PHARMACY MARKET, BY TYPE, 2018-2032 (USD MILLION)
TABLE 10 CANADA SPECIALTY PHARMACY MARKET, BY CONDITION, 2018-2032 (USD MILLION)
List of Figure
FIGURE 1 CANADA SPECIALTY PHARMACY MARKET: SEGMENTATION
FIGURE 2 CANADA SPECIALTY PHARMACY MARKET: DATA TRIANGULATION
FIGURE 3 CANADA SPECIALTY PHARMACY MARKET: DROC ANALYSIS
FIGURE 4 CANADA SPECIALTY PHARMACY MARKET: COUNTRYWISE MARKET ANALYSIS
FIGURE 5 CANADA SPECIALTY PHARMACY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 CANADA SPECIALTY PHARMACY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 CANADA SPECIALTY PHARMACY MARKET: DBMR MARKET POSITION GRID
FIGURE 8 CANADA SPECIALTY PHARMACY MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 9 CANADA SPECIALTY PHARMACY MARKET: SEGMENTATION
FIGURE 10 THREE SEGMENTS COMPRISE THE CANADA SPECIALTY PHARMACY MARKET, BY SERVICE TYPE (2024)
FIGURE 11 STRATEGIC DECISIONS
FIGURE 12 AN INCREASE IN THE PREVALENCE OF CHRONIC AND RARE DISEASES IS EXPECTED TO BOOST THE CANADA SPECIALTY PHARMACY MARKET IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 13 THE CLINICAL SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE CANADA SPECIALTY PHARMACY MARKET IN 2025 & 2032
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF CANADA SPECIALITY PHARMACY MARKET
FIGURE 15 CANADA SPECIALTY PHARMACY MARKET: BY TYPE, 2024
FIGURE 16 CANADA SPECIALTY PHARMACY MARKET: BY TYPE, 2025-2032 (USD MILLION)
FIGURE 17 CANADA SPECIALTY PHARMACY MARKET: BY TYPE, CAGR (2025-2032)
FIGURE 18 CANADA SPECIALTY PHARMACY MARKET: BY TYPE, LIFELINE CURVE
FIGURE 19 CANADA SPECIALTY PHARMACY MARKET: BY SERVICE TYPE, 2024
FIGURE 20 CANADA SPECIALTY PHARMACY MARKET: BY SERVICE TYPE, 2025-2032 (USD MILLION)
FIGURE 21 CANADA SPECIALTY PHARMACY MARKET: BY SERVICE TYPE, CAGR (2025-2032)
FIGURE 22 CANADA SPECIALTY PHARMACY MARKET: BY SERVICE TYPE, LIFELINE CURVE
FIGURE 23 CANADA SPECIALTY PHARMACY MARKET: BY CONDITION, 2024
FIGURE 24 CANADA SPECIALTY PHARMACY MARKET: BY CONDITION, 2025-2032 (USD MILLION)
FIGURE 25 CANADA SPECIALTY PHARMACY MARKET: BY CONDITION, CAGR (2025-2032)
FIGURE 26 CANADA SPECIALTY PHARMACY MARKET: BY CONDITION, LIFELINE CURVE
FIGURE 27 CANADA SPECIALTY PHARMACY MARKET: COMPANY SHARE 2024 (%)



